The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Jae Ha LeeJi Hoon JangJin Han ParkHang-Jea JangChan Sun ParkSunggun LeeSeong-Ho KimJi Yeon KimHyun Kuk KimPublished in: PloS one (2021)
In our study, a high level of serum IL-6 is a useful biomarker to predict AE and poor prognosis in patients with ILD.